Canadian Biopharma Stock Powers Higher on Update

Liminal BioSciences Inc. (TSX:LMNL), a Canadian biopharma stock, climbed after announcing a fezagepras clinical study update

Sean Mason | July 2, 2020 | SmallCapPower

A COVID-19 and clinical study update propelled a Canadian biopharma stock Thursday. Here’s some small stocks making big moves on Thursday, July 2, 2020 (as of 4 pm EST):

Liminal BioSciences Inc. (TSX:LMNL), a Canadian biopharma stock, surged 62% to $23 on Thursday after announcing that its multiple ascending dose Phase 1 clinical study of fezagepras is expected to be initiated in the second half of 2020. The Company also reported that its Prometic Plasma Resources subsidiary has joined the CoVIg-19 Plasma Alliance to contribute to the acceleration of the development of a potential new therapy for COVID-19.

Win Big With Our Small Cap Picks

 

As well, shares of Prime Mining Corp. (TSXV:PRYM) gained 9% to $1.42 as the junior explorer revealed sample results from the Company’s ongoing surface exploration program on the Los Reyes project in Mexico, which included 63.0 metres of 1.78 grams per tonne (g/t) gold and 71.0 g/t silver.

Meanwhile, Global Crossing Airlines Inc. (TSXV:JET), formerly Canada Jetlines, reported that it and Breeze Airways have reached an amicable agreement to settle a lawsuit brought by Canada Jetlines in November 2019. Global Crossing Airlines stock flew 39% to $2.55 following the announcement.

Finally, Datametrex AI Limited (TSXV:DM) shares rose 18% to $0.10 after the Artificial Intelligence and Machine Learning focused technology company announced a $2.6 million per annum sales agreement with SeeS Solutions Inc.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: